Leviticus Cardio is developing a wireless system able to provide the day-to-day power needs of VAD implants while eliminating the complications related to the drive line.
The Company’s solution uses a proprietary technology, Coplanar Energy Transfer (CET), that works with available commercial LVADs, including market-leading HM3 (HeartMate) and HVAD® (HeartWare). The innovative CET system provides effective transcutaneous energy transfer with important advantages over competing wireless energy transfer technologies —
Stage: Business development
Investors: The Trendlines Group, Maryland/Israel Trendlines Fund, M.D.s and VAD expert group, Israel’s Office of the Chief Scientist grants
IP: 8 issued patents; 4 pending in the United States
Thousands of patients each year are candidates for heart transplantation. An alternative to heart transplantation is the ventricular assist device (VAD), an implanted mechanical circulatory pump that is increasingly being used to support patients with heart failure.
To supply power to the pump, the VAD is connected to an external power pack by a transcutaneous drive line. The exit site of the drive line on the abdomen provides a port of entry for pathogens, making VAD recipients highly vulnerable to device-related infections. Infection and reduction in quality of life (both related to the drive line) represent the most important challenge to extended VAD use.
The total available market (TAM) of VADs is estimated at $4 billion, with current sales of $800 million. VADs are projected to become the main intervention measure in the treatment of heart failure.
Leviticus estimates the TAM for its CET system at $900 million. Players in the VAD market include St. Jude Medical, HeartWare, Jarvik Heart, Cleveland Heart, Sunshine Heart, CorWave, Rein VAD (AME), Calon Cardio, Berlin Heart, and Relight Heart.
See the company one-page description in Chinese (PDF).
Michael Zilbershlag presents at Trendlines Medical Asia Road Show.
See an animation of the Leviticus Cardio system.
Michael Zilbershlag presents at a Trendlines Showcase.
Cryotherapy for bladder illnesses
Endoscopic ultrasound fine needle biopsy
Portable, automatic system for peritoneal dialysis
Device for treating ischemic stroke
Anastomotic closure device for laparoscopic bowel resection
Miniature screwless implant for facet joint fusion